PLA2G7 and familial isolated congenital asplenia: In patients with ICAS, Lp-PLA2 elevations were found to be associated with plaque enhancement and surface irregularity, and combined assessments of Lp-PLA2 concentration and plaque enhancement were of greater diagnostic value for the risk of AIS in patients with ICAS (30).